Improving Antimicrobial Prescribing Practices in the Neonatal Intensive Care Unit

改善新生儿重症监护病房的抗菌药物处方实践

基本信息

  • 批准号:
    7483849
  • 负责人:
  • 金额:
    $ 80.18万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-07-24 至 2013-04-30
  • 项目状态:
    已结题

项目摘要

The increased emergence of antibiotic resistance has been linked to the overuse of antibiotics, particularly in hospitals. Antimicrobial stewardship programs are widely acknowledged as essential to improve appropriate antibiotic use, decrease antimicrobial resistance, and reduce cost. However, few data exist describing the efficacy of such programs in pediatric populations, particularly in the neonatal intensive care unit (NICU). The long-term objectives of this study are to reduce antimicrobial resistance by implementing innovative interdisciplinary interventions aimed to improve antibiotic prescribing practices in the NICU and thereby define the optimal interventions for this population. The Specific Aims are to: 1) measure the impact of three interdisciplinary intervention bundles on inappropriate antimicrobial use as categorized by the CDC 12 Step Campaign Program to Prevent Antimicrobial Resistance; 2) determine the impact of these . intervention bundles on resistance density, i.e., changes in the rate of infant infections and colonization with multidrug-resistant organisms (MDROs) and changes in the proportion of MDROs carried on NICU staff hands; and 3) determine the cost effectiveness of the intervention bundles in preventing bloodstream infections caused by MDROs. The Study Design is a quasi-experimental prospective clinical trial whereby 4 study NICUs in the United States (total beds - 214, annual discharges - 3649) will berandomized to successive bundles of interventions versus usual care to determine which combinations of interventions have the greatestjmpact on appropriate antibiotic use, antimicrobial resistance, and cost. The interventions have beendeveloped using the PRECEDE-PROCEEDhealth promotion planning model which suggests that programsto change health behavior should include predisposing, enabling, and reinforcing factors. Thus, the Education intervention in this study addresses the predisposing knowledge and beliefs of staff regarding antimicrobial resistance and helps set goals for improving prescribing practices. The Clinical Decision Support- Computerized Provider Order Entry intervention provides computer prompts in the electronic health record to enable better decisions about stopping, changing, or continuing antibiotic treatment. The Audit and Prescriber Feedback intervention reinforces desired prescribing practices as providers can monitor the success of their prescribing decisions on health outcomes and receive praise and encouragement from the study team.
抗生素耐药性的增加与抗生素的过度使用有关, 在医院里抗菌药物管理计划被广泛认为是改善 适当使用抗生素,减少抗生素耐药性,降低成本。然而,几乎没有数据 描述了这些项目在儿科人群中的效果,特别是在新生儿重症监护中, 单位(NICU)。本研究的长期目标是通过实施抗生素耐药性 创新的跨学科干预措施,旨在改善NICU的抗生素处方实践, 从而为这一人群确定最佳干预措施。具体目标是:1)衡量影响 疾病预防控制中心分类的三个跨学科干预包, 预防抗生素耐药性的12步运动计划; 2)确定这些措施的影响。 干预束的阻力密度,即,婴儿感染率的变化和 多重耐药微生物(MDRO)和NICU工作人员携带MDRO比例的变化 手; 3)确定干预措施在预防血流方面的成本效益 MDRO引起的感染。 研究设计是一项准实验性前瞻性临床试验,其中4个研究NICU在美国 国家(总床位- 214,年排放量- 3649)将berandomized到连续束 干预与常规护理,以确定哪种干预组合的影响最大 抗生素的适当使用、耐药性和成本。干预措施已经制定 使用PRECEDE-PROCEED健康促进规划模型,该模型建议改变 健康行为应包括诱发因素、促成因素和强化因素。因此,教育 本研究中的干预措施涉及工作人员对抗菌药物的易感知识和信念, 阻力,并帮助制定目标,改善处方做法。临床决策支持- 计算机化供应商订单输入干预在电子健康记录中提供计算机提示, 更好地决定停止,改变或继续抗生素治疗。审计和 处方者反馈干预加强了所需的处方实践,因为提供者可以监控 他们的处方决定对健康结果的成功,并得到赞扬和鼓励, 学习团队。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LISA SAIMAN其他文献

LISA SAIMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LISA SAIMAN', 18)}}的其他基金

Improving Antimicrobial Prescribing Practices in the Neonatal Intensive Care Unit
改善新生儿重症监护病房的抗菌药物处方实践
  • 批准号:
    7812091
  • 财政年份:
    2008
  • 资助金额:
    $ 80.18万
  • 项目类别:
Improving Antimicrobial Prescribing Practices in the Neonatal Intensive Care Unit
改善新生儿重症监护病房的抗菌药物处方实践
  • 批准号:
    8063665
  • 财政年份:
    2008
  • 资助金额:
    $ 80.18万
  • 项目类别:
Improving Antimicrobial Prescribing Practices in the Neonatal Intensive Care Unit
改善新生儿重症监护病房的抗菌药物处方实践
  • 批准号:
    8257542
  • 财政年份:
    2008
  • 资助金额:
    $ 80.18万
  • 项目类别:
Improving Antimicrobial Prescribing Practices in the Neonatal Intensive Care Unit
改善新生儿重症监护病房的抗菌药物处方实践
  • 批准号:
    7663735
  • 财政年份:
    2008
  • 资助金额:
    $ 80.18万
  • 项目类别:
Susceptibility Testing, Treatment Choices, and Outcomes of MDR-GNB Infections
MDR-GNB 感染的药敏试验、治疗选择和结果
  • 批准号:
    7676233
  • 财政年份:
    2007
  • 资助金额:
    $ 80.18万
  • 项目类别:
Applied Research in Antimicrobial Resistance: Studies of Susceptibility Testing
抗菌素耐药性的应用研究:药敏试验研究
  • 批准号:
    7415362
  • 财政年份:
    2007
  • 资助金额:
    $ 80.18万
  • 项目类别:
Training in Pediatric Infectious Diseases
儿科传染病培训
  • 批准号:
    8301673
  • 财政年份:
    1998
  • 资助金额:
    $ 80.18万
  • 项目类别:
Training in Pediatric Infectious Diseases
儿科传染病培训
  • 批准号:
    7883211
  • 财政年份:
    1998
  • 资助金额:
    $ 80.18万
  • 项目类别:
Training in Pediatric Infectious Diseases
儿科传染病培训
  • 批准号:
    8092741
  • 财政年份:
    1998
  • 资助金额:
    $ 80.18万
  • 项目类别:
TB IN CHILDREN--EPIDEMIOLOGY DIAGNOSTIC METHODS AND NOSOCOMIAL TRANSMISSION
儿童结核病--流行病学诊断方法和院内传播
  • 批准号:
    6117700
  • 财政年份:
    1998
  • 资助金额:
    $ 80.18万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 80.18万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 80.18万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 80.18万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 80.18万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 80.18万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 80.18万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 80.18万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 80.18万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 80.18万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 80.18万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了